Keros Therapeutics (KROS) Cash from Investing Activities (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Cash from Investing Activities (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Keros Therapeutics | 383.01 Mn | 95.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.52% |
| Sep 30, 2025 | 81.67% |
| Jun 30, 2025 | -27.43% |
| Mar 31, 2025 | -95.50% |
| Dec 31, 2024 | 25.13% |
| Sep 30, 2024 | -24.52% |
| Jun 30, 2024 | 67.23% |
| Mar 31, 2024 | -74.86% |
| Dec 31, 2023 | 1.64% |
| Sep 30, 2023 | -76.85% |
| Jun 30, 2023 | 70.72% |
| Mar 31, 2023 | -202.56% |
| Dec 31, 2022 | -99.43% |
| Sep 30, 2022 | 68.96% |
| Jun 30, 2022 | -285.71% |
| Mar 31, 2022 | 7.55% |
| Dec 31, 2021 | -9.66% |
| Sep 30, 2021 | 71.57% |
| Jun 30, 2021 | -142.86% |
| Mar 31, 2021 | -250.00% |